CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration
CANbridge Pharmaceuticals Returns Nerlynx Rights to Puma in Greater China BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge…
CANbridge Pharmaceuticals Returns Nerlynx Rights to Puma in Greater China BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge…
CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--$BGNE #BTKi--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company…
CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc.’s (“Coeur” or the “Company”) (NYSE: CDE) President and Chief Executive Officer,…
Puma Biotechnology and CANbridge Pharmaceuticals Terminate License Agreement in Greater China LOS ANGELES & CASTRES,…
Sureka's Appointment is the Latest in a Focused Talent Strategy to Maximize Growth and Long-Term…
Startek Acquires ~26% Indirect Beneficial Interest in CSS Corp; Has Option to Acquire Majority Stake…
SYDNEY & NEW YORK--(BUSINESS WIRE)--AMP Limited (“AMP”) and Ares Management Corporation (NYSE: ARES) (“Ares”) today…
Joins forces with TCL Hofmann and Stratasys to bring proven FDM® 3D printing solution for…
Multiyear collaboration to advance innovation in therapeutics and biomedical technology platforms CAMBRIDGE, Mass. & TOKYO--(BUSINESS…
DUBLIN--(BUSINESS WIRE)--The "India Orthopedic Devices Market, By Product Type (Joint Reconstruction, Spinal Devices, Orthopedic Braces…